Latest news
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:10:10 GMTFierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 12:35:10 GMTBraveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 12:27:37 GMTBlossomHill eyes $112M IPO harvest to fund Tagrisso challenger - Fierce BiotechFierce Biotech · Mon, 03 Aug 2026 13:18:47 GMTApnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 07:00:00 GMTAttovia, Braveheart and Vogenx seek more than $500M via IPOs - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMT